Classifying the Microbiota
Bioinformatic Challenges in Microbiome Analyses
Skin: A New Target for Microbiota Interventions
Developing Live Biotherapeutic Products
Call for Abstracts
Pharmabiotics 2018 focuses on the science and business of new research and technologies for treating diseases and sustaining health via the Human Microbiota.
If you are an expert in the field, either from Academia or Industry and have research to present (verbal or poster), we would like to hear from you!
Please complete the form on the right, following the specified guidelines:
Abstract Submission Guidelines
Only abstracts on recent original research related to the influence of the microbiota, as well as the analytical tools, therapeutic potential, mechanisms of action, pre-clinical and clinical efficacy in the treatment or prevention of pathologies will be accepted.
Length Up to 300 words are accepted. Abstracts cannot include tables or figures.
Only standardized abbreviations will be allowed. Any abbreviation should be explained in brackets the first time it appears in the text.
Selection will be carried out on the basis of overall quality of the abstract and special interest by the scientific committee. Abstract acceptance or rejection will be notified by e-mail along with presentation criteria and other details.
The scientific committee reserves the rights to reject proposals that are beyond the scope of the conference.
Submissions imply the intent of at least one author to register, attend the conference and present the study. The author has to be registered before January 31st 2018.